Award
NIH Reporter #1R43CA295316-01A1
Development of a metabolomics enabled AI/ML platform for discovery of new treatments to enhance drug sensitivity in cancer
Recipient
Not specified
Awarded
September 18, 2025
Identifier
1R43CA295316-01A1
NIH grant awarded by the National Cancer Institute to develop AI/ML algorithms using metabolomics data to discover new cancer treatments that improve drug sensitivity.
Description
This is a NIH grant opportunity for research on metabolomics-based data-driven drug discovery in cancer. The project aims to develop algorithms and validate methods to predict drug sensitivity and enhance cancer treatment options.